Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL001168

Drug Information
IndicationBreast Cancer, Gastric/GE Junctional Cancer, Hepatocellular Carcinoma, Melanoma, Castration-Resistant Prostate Cancer, Non-small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Small Cell Lung Cance
[ICD9: 140-229, 155, 157, 162, 172, 174, 175, 183, 185, 204.0   ICD10: C00-C96, C22.0, C25, C33, C33-C34, C34, C43, C50, C56, C61, C91.0]
Phase II    [1]
Differentiated Thyroid Cancer, Renal Cell Carcinoma
[ICD9: 140-229, 189, 193   ICD10: C00-C96, C64, C73]
Phase Ib    [1]
Medullary Thyroid Cancer
[ICD9: 193   ICD10: C73]
Phase III    [1]
Metastatic Castration-Resistant Prostate Cancer, Ovarian Cancer
[ICD9: 140-229, 183, 185   ICD10: C00-C96, C56, C61]
Phase II    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCOC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F    
CAS NumberCAS 849217-68-1
PubChem Compound IDCID 25102847.
TargetMet proto-oncogene tyrosine kinaseInhibitor[1]
Met proto-oncogene tyrosine kinaseMultitarget[1]
Vascular endothelial growth factor receptor 2Inhibitor[1]
Vascular endothelial growth factor receptor 2Multitarget[1]
Ref 12011 Pipeline of Exelixis. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543